Skip to main content
Equibles

GRANULES · Granules India Limited · Documents

Use GRANULES with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GRANULES.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
813.20 INR -27.30 (-3.25%) At close · Nov 13
Rebalance outlook locked
Market Cap
201.51B INR
Shares
247.80M
Volume · Nov 13 1.23M Avg daily vol (3M) 1.18M

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 2, 2026
2026
Nov 2
Earnings call
Revenue rises 20% as PAT grows 39%

Granules India Limited reported revenue of INR15,600 million, up 20% year-on-year, and PAT growth of 39%; the U.S. FDA issued eleven observations at Gagillapur, which management said did not affect manufacturing or distribution.

4 source passages
Granules India Limited Revenue grew 20% year-on-year to INR15,600 million, crossing INR15,000 million in quarterly revenue for the first time in our history. EBITDA grew 21%, while PAT increased 39% to INR1,818 million. The inspection concluded with a Form 483 containing eleven observations. There is no impact on manufacturing or distribution of products from this site. Open the document at this passage
Showing 1–2 of 2 documents